Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)

Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)

<p>Abstract</p> <p>Background</p> <p>Recent evidence suggests that there may be a bidirectional, physiological link between hypogonadism and metabolic syndrome (MetS), and testosterone replacement therapy (TRT) has been shown to improve some symptoms of MetS in small pa...

Full description

Bibliographic Details
Main Authors: Kushner Harvey, Blick Gary, Khera Mohit, Bhattacharya Rajib K, Nguyen Dat, Miner Martin M
Format: Article
Language:English
Published: BMC 2011-11-01
Series:BMC Endocrine Disorders
Subjects:
Testosterone
metabolic syndrome
obesity
testosterone gel
testosterone replacement
TRiUS registry
Testim
hypogonadism
testosterone deficiency
fasting glucose
Online Access:http://www.biomedcentral.com/1472-6823/11/18

Internet

http://www.biomedcentral.com/1472-6823/11/18

Similar Items